Roberto Pinazo-Gallego - Publications

Peripapillary Choroidal Neovascularization in Adults: Spectrum of Etiologies and Clinical Features.

Journal: Investigative ophthalmology & visual science

Published: May 14, 2026

Photodynamic therapy in neovascular age-related macular degeneration: Past or present in the era of second-generation anti-VEGF agents?

Journal: Archivos de la Sociedad Espanola de Oftalmologia

Published: February 22, 2026

Rapid Fluid Resolution and Durability With Faricimab in Neovascular Age-Related Macular Degeneration.

Journal: JAMA ophthalmology

Published: February 19, 2026

Macular Neovascularization in Neovascular Age-Related Macular Degeneration: A Systematic Review of OCT Angiography-based Assessments and Challenges in Standardization.

Journal: Ophthalmology. Retina

Published: January 15, 2026

Vascular endothelial growth factor inhibitors outcomes in good vision eyes with neovascular age-related macular degeneration: Fight Retinal Blindness! SPAIN Report 4.

Journal: Canadian journal of ophthalmology. Journal canadien d'ophtalmologie

Published: August 02, 2025

OCTA in age-related macular degeneration: consensus on practical guidelines for optimal imaging strategies across different clinical scenarios.

Journal: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie

Published: June 25, 2025

Predictors of Macular Atrophy after Serous Pigment Epithelial Detachment Collapse in Type 3 Macular Neovascularization and Age-Related Macular Degeneration.

Journal: Ophthalmology. Retina

Published: March 30, 2025

Imaging-Guided Classification of Neovascularization in Neovascular Age-Related Macular Degeneration: Progress to Date.

Journal: Journal of vitreoretinal diseases

Published: November 14, 2024

Disease Activity Criteria Impact Dosing Interval Assignment in Neovascular Age-related Macular Degeneration Trials.

Journal: Ophthalmology. Retina

Published: September 19, 2024

Topographical Quantification of Retinal Fluid in Type 3 MNV and Associations With Short-Term Visual Outcomes.

Journal: American journal of ophthalmology

Published: March 24, 2024

Fight Retinal Blindness SPAIN. Report 3: clinical outcomes of vascular endothelial growth factor inhibitors in low vision eyes with neovascular age-related macular degeneration. A national database study.

Journal: Eye (London, England)

Published: January 22, 2024

Astigmatism Influences Quantitative and Qualitative Analysis in Optical Coherence Tomography Angiography Imaging.

Journal: Translational vision science & technology

Published: January 15, 2024